(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)

C51H49N3O2Pt — CID 170932557

IUPAC(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)
SMILESCC(C)(C)c1ccnc(N2c3[c-]c(Oc4[c-]c(C5=N[C@H](C6CCCCC6)[C@@H](c6ccccc6)O5)cc(-c5ccccc5)c4)ccc3C(C)(C)c3ccccc32)c1.[Pt+2]
InChIInChI=1S/C51H49N3O2.Pt/c1-50(2,3)39-27-28-52-46(32-39)54-44-24-16-15-23-42(44)51(4,5)43-26-25-40(33-45(43)54)55-41-30-37(34-17-9-6-10-18-34)29-38(31-41)49-53-47(35-19-11-7-12-20-35)48(56-49)36-21-13-8-14-22-36;/h6,8-10,13-18,21-30,32,35,47-48H,7,11-12,19-20H2,1-5H3;/q-2;+2/t47-,48-;/m1./s1
InChIKeyMEBRROJIOGKXOE-YQGNRGSNSA-N
MW931.05 g/mol
LogP13.01
Rot. Bonds7

About (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)

(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) (PubChem CID 170932557) has the molecular formula C51H49N3O2Pt and a molecular weight of 931.05 g/mol. Its IUPAC name is (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+).

Molecular Properties

Compound Name(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)
PubChem CID170932557
Molecular FormulaC51H49N3O2Pt
Molecular Weight931.05 g/mol
Exact Mass930.35
IUPAC Name(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)
SMILESCC(C)(C)c1ccnc(N2c3[c-]c(Oc4[c-]c(C5=N[C@H](C6CCCCC6)[C@@H](c6ccccc6)O5)cc(-c5ccccc5)c4)ccc3C(C)(C)c3ccccc32)c1.[Pt+2]
InChIInChI=1S/C51H49N3O2.Pt/c1-50(2,3)39-27-28-52-46(32-39)54-44-24-16-15-23-42(44)51(4,5)43-26-25-40(33-45(43)54)55-41-30-37(34-17-9-6-10-18-34)29-38(31-41)49-53-47(35-19-11-7-12-20-35)48(56-49)36-21-13-8-14-22-36;/h6,8-10,13-18,21-30,32,35,47-48H,7,11-12,19-20H2,1-5H3;/q-2;+2/t47-,48-;/m1./s1
InChIKeyMEBRROJIOGKXOE-YQGNRGSNSA-N
XLogP13.01
TPSA46.95 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500931.05
LogP ≤ 513.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)?
The IUPAC name of (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) (CID 170932557) is (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+).
What is the SMILES notation for (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)?
The canonical SMILES for (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) is CC(C)(C)c1ccnc(N2c3[c-]c(Oc4[c-]c(C5=N[C@H](C6CCCCC6)[C@@H](c6ccccc6)O5)cc(-c5ccccc5)c4)ccc3C(C)(C)c3ccccc32)c1.[Pt+2].
What is the InChIKey of (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)?
The InChIKey is MEBRROJIOGKXOE-YQGNRGSNSA-N. The full InChI is InChI=1S/C51H49N3O2.Pt/c1-50(2,3)39-27-28-52-46(32-39)54-44-24-16-15-23-42(44)51(4,5)43-26-25-40(33-45(43)54)55-41-30-37(34-17-9-6-10-18-34)29-38(31-41)49-53-47(35-19-11-7-12-20-35)48(56-49)36-21-13-8-14-22-36;/h6,8-10,13-18,21-30,32,35,47-48H,7,11-12,19-20H2,1-5H3;/q-2;+2/t47-,48-;/m1./s1.
What are the key properties of (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+)?
(4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) has a molecular weight of 931.05 g/mol, XLogP of 13.01, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,5R)-2-[3-[[10-(4-tert-butyl-2-pyridinyl)-9,9-dimethyl-4H-acridin-4-id-3-yl]oxy]-5-phenylbenzene-2-id-1-yl]-4-cyclohexyl-5-phenyl-4,5-dihydro-1,3-oxazole;platinum(2+) is sourced from PubChem (CID 170932557), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).